Characterizing TP53 mutations in ovarian carcinomas with and without concurrent BRCA1 or BRCA2 mutations
Talayeh Ghezelayagh, Kathryn P. Pennington, Barbara M. Norquist, Nithisha Khasnavis, Marc R. Radke, Mark Kilgore, Rochelle L. Garcia, Ming Lee, Ronit Katz, Kimberly K. Leslie, Rosa Ana Risques, Elizabeth M. Swisher
Topics & Concepts
BRCA mutationMedicineOncologyMutationOvarian cancerInternal medicineProportional hazards modelLogistic regressionSerous carcinomaMutation rateCancerOvarian carcinomaGeneticsCancer researchGeneBiologyPopulationEnvironmental healthOvarian cancer diagnosis and treatmentPARP inhibition in cancer therapyCancer-related Molecular Pathways